WallStreetZenWallStreetZen

NASDAQ: TVRD
Tvardi Therapeutics Inc Stock Ownership - Who owns Tvardi Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Tvardi Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Christopher PosnerPRESIDENT AND CEO2025-02-28583$4.75
$2.77kSell
Scott TerrillionSECY CHIEF COMPLIANCE G.C.2025-02-28163$4.76
$775.88Sell
Christopher PosnerPRESIDENT AND CEO2025-02-04372$4.72
$1.76kSell
Christopher PosnerPRESIDENT AND CEO2024-11-043,668$0.29
$1.06kSell
Christopher PosnerPRESIDENT AND CEO2024-08-014,149$0.35
$1.45kSell

1 of 1

TVRD insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TVRD insiders and whales buy or sell their stock.

TVRD Shareholders

What type of owners hold Tvardi Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Csl Ltd161.73%7,396,770$197.72MInsider
Vifor International Ltd161.73%7,396,770$197.72MInsider
Dean Slagel85.84%3,925,825$104.94MInsider
Rho Ventures VI LP78.01%3,568,057$95.37MInsider
Martin Vogelbaum76.07%3,479,064$93.00MInsider
Charles Phd Moller34.47%1,576,404$42.14MInsider
Derek T. Chalmers21.68%991,405$26.50MInsider
Shaheen Wirk9.69%443,385$11.85MInsider
Samuel David Tweardy6.90%315,658$8.44MInsider
Michael E. Lewis6.89%314,988$8.42MInsider

1 of 3

TVRD vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TVRD3.45%96.55%Net SellingNet Selling
PPBT0.02%0.00%
THTX30.23%0.00%
EDIT60.74%39.26%Net SellingNet Selling
NKTR71.41%14.11%Net SellingNet Selling
View Top Biotech Stocks

Tvardi Therapeutics Stock Ownership FAQ

Who owns Tvardi Therapeutics?

Tvardi Therapeutics (NASDAQ: TVRD) is owned by 24.14% institutional shareholders, 674.69% Tvardi Therapeutics insiders, and 0.00% retail investors. Csl Ltd is the largest individual Tvardi Therapeutics shareholder, owning 7.40M shares representing 161.73% of the company. Csl Ltd's Tvardi Therapeutics shares are currently valued at $205.56M.

If you're new to stock investing, here's how to buy Tvardi Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.